3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Methods
5
Surveys and Questionnaires
3
Radiosurgery
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Early Intervention, Educational
3
Brachytherapy
3
Biopsy
3
aflibercept
2
Vaccines, Synthetic
2
Vaccines
2
Trastuzumab
2
Sentinel Lymph Node Biopsy
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Papillomavirus Vaccines
2
Palliative Care
2
Counseling
2
Cisplatin
2
tremelimumab
1
tipifarnib
1
pembrolizumab
1
oncogene protein E7, Human papillomavirus type 16
1
nanocis
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
durvalumab
1
alovudine
1
aldesleukin
1
Wound Closure Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Vulvar Neoplasms
×
Molecular Diagnostic Techniques
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled